Get the Stockscreener App
5.14
3.63%
0.1799
After Hours:
5.00
-0.14
-2.72%
Endra Life Sciences Inc stock is traded at $5.14, with a volume of 7,470.
It is up +3.63% in the last 24 hours and up +48.13% over the past month.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
See More
Previous Close:
$4.9601
Open:
$5
24h Volume:
7,470
Relative Volume:
0.07
Market Cap:
$6.38M
Revenue:
-
Net Income/Loss:
$-7.03M
P/E Ratio:
-0.5767
EPS:
-8.9134
Net Cash Flow:
$-8.20M
1W Performance:
-0.58%
1M Performance:
+48.13%
6M Performance:
-30.63%
1Y Performance:
+62.66%
1-Day Range:
$4.916
$5.16
1-Week Range:
$4.74
$5.38
52-Week Range:
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
5.14 | 6.15M | 0 | -7.03M | -8.20M | -8.9134 |
TMO
Thermo Fisher Scientific Inc
|
531.67 | 195.93B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
198.14 | 140.56B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
580.76 | 46.39B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
119.77 | 34.02B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
326.20 | 32.49B | 3.17B | 642.63M | 516.49M | 10.77 |
Endra Life Sciences Inc Stock (NDRA) Latest News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS Registered Liver Imaging Technology - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology - Barchart.com
Aug Fed Impact: What is the PEG ratio of ENDRA Life Sciences IncMarket Movers & Fast Momentum Entry Tips - baoquankhu1.vn
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
Aug Fed Impact: Whats the MACD signal for ENDRA Life Sciences IncGDP Growth & Long-Term Safe Investment Ideas - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside - Barchart.com
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 - openPR.com
Retail Surge: Is ENDRA Life Sciences Inc exposed to currency risks2026 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - FinancialContent
ENDRA Life Sciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView — Track All Markets
ENDRA (NDRA) Optimistic About TAEUS Technology's Potential - GuruFocus
ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) flags going-concern risk and pivots to digital asset treasury - Stock Titan
ENDRA Life Sciences | 8-K: ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Moomoo
ENDRA Life Sciences Q4 net loss narrows - TradingView — Track All Markets
Form 8-KCurrent report - ADVFN
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - ChartMill
Day Trade: Whats the MACD signal for ENDRA Life Sciences Inc2026 Market Overview & Daily Entry Point Alerts - baoquankhu1.vn
ENDRA Life Sciences (NASDAQ: NDRA) cuts 2025 operating costs sharply - Stock Titan
Movement Recap: Does ENDRA Life Sciences Inc outperform in volatile marketsWeekly Market Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
ENDRA Life Sciences (NDRA) Expected to Announce Earnings on Monday - National Today
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
NDRA Ignites: 20% Surge Signals Strategic Overhaul as Capital Hunt for Micro-Cap Alphas - Bitget
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
ENDRA Life Sciences Explores Strategic Alternatives Amid Restructuring - The Globe and Mail
ENDRA Life Sciences explores strategic alternatives By Investing.com - in.investing.com
Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside - FinancialContent
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value - BioSpace
Strategic options review launched by ENDRA Life Sciences (Nasdaq: NDRA) - Stock Titan
ENDRA Life Sciences explores strategic alternatives - Investing.com
ENDRA (NDRA) Explores Strategic Options to Enhance Shareholder V - GuruFocus
ENDRA Life Sciences Inc. Initiates Review of Strategic Alternatives to Maximize Shareholder Value - marketscreener.com
ENDRA Life Sciences Inc announced that its Board of Directors has initiated a strategic review process aimed at a comprehensive assessment of the company’s future development pathways. - Bitget
ENDRA Life Sciences (NDRA) Expected to Announce Quarterly Earnings on Monday - Defense World
If You Invested $1,000 in Endra Life Sciences Inc (NDRA) - Stock Titan
Tech Rally: Is ENDRA Life Sciences Inc being accumulated by smart money2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
Stocks Under $10: IBRX, VTIX, NDRA, SMX2026 Watch Now! - openPR.com
Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - The Norfolk Daily News
IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - FinancialContent
ENDRA Life Sciences (NASDAQ: NDRA) - MarketScreener
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play In The $100B+MASH+GLP-1 Healthcare Boom - Mena FN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
User - The Chronicle-Journal
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now! - Barchart.com
FinancialContentFavorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - FinancialContent
Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA - FinancialContent
Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - Barchart
Favorable Results on Liver Device for Long-Term Monitoring - openPR.com
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.41%
1.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):